Abstract
INTRODUCTION
Chronic kidney disease (CKD) has become a common morbidity in the current era, and it is expected to become rapidly more prevalent in the next few decades due to the growing incidence of metabolic diseases [1, 2] . Severe CKD is a well-known risk factor for cardiovascular disease-particularly ischaemic heart disease. Consequently, a growing number of patients with severe CKD are expected to be treated with revascularization for coronary artery disease [3] .
In selecting revascularization strategies for patients with severe CKD, the current guidelines [4, 5] acknowledged the superiority of coronary artery bypass grafting (CABG) over percutaneous coronary intervention based on survival benefits in a selected set of patients with reasonable life expectancy. The guidelines suggest that CABG may be preferentially performed in these patients weighing against the increased rate of perioperative complications, although CABG should not be performed in this cohort with limited life expectancy [4, 5] .
However, the optimal surgical strategy regarding the use of cardiopulmonary bypass (CPB) during CABG in patients with severe CKD is under debate. Off-pump CABG (OPCAB) has been suggested as an attractive option for high-risk patients based on postulated physiological benefits of avoiding CPB [6, 7] . In recent studies, however, patients receiving OPCAB did not demonstrate long-term survival benefits, which is presumably attributable to the tendency of incomplete revascularization and worse graft patency associated with OPCAB [8, 9] . Only a few studies have compared the clinical outcomes between the on-pump and the off-pump strategies in patients with severe CKD receiving CABG. Additionally, the conclusions of those studies showed mixed results with respect to major clinical outcomes, especially mortality [10] [11] [12] [13] .
Therefore, we sought to compare the early and long-term clinical outcomes in patients with severe CKD undergoing CABG with on-or off-pump strategies to evaluate the clinical impact of CPB use in this high-risk cohort.
METHODS

Study population
From January 1997 to December 2015, a total of 7063 consecutive patients underwent CABG in our institution and were registered in our institutional prospective cardiac surgery database. Among them, we identified 321 patients with severe CKD who had undergone elective isolated CABG for multivessel coronary artery disease; of these, 118 underwent CABG using CPB (onpump group), whereas 203 underwent OPCAB (off-pump group). Among the 203 patients in the off-pump group, 6 (3.0%) patients were planned to undergo OPCAB preoperatively but converted to on-pump CABG intraoperatively. These patients were assigned to the off-pump group based on the intention-to-treat analyses.
CKD was defined to be severe for an estimated glomerular filtration rate <30 ml/min/1.73 m 2 according to the definition and classification set forth by the National Kidney Foundation [14] . The decision to perform on-or off-pump CABG was influenced by each patient's demographic and clinical profiles but finally left at the discretion of the operating surgeon; each operating surgeon had a different strategy with regard to the use of CPB during CABG. This study was approved by the institutional review board and ethics committee of Asan Medical Center. The requirements for informed consent were waived due to the retrospective nature of the study design.
Surgical procedures
All patients underwent CABG through a median full sternotomy. In situ left internal mammary artery was always preferred as the first choice for revascularization of the left anterior descending coronary territory whenever feasible. Left internal mammary arteries were skeletonized or dissected as a pedicle according to the surgeon's preference. The choice of grafting conduits and the employment of a sequential technique for the secondary target vessels were affected by the target coronary territories, graft conduit availability and the surgeon's preference, considering such factors to achieve complete revascularization.
For patients undergoing on-pump CABG, CPB was instituted by cannulating the ascending aorta and right atrium after systemic heparinization (300 IU/kg) with a target activated clotting time of > _480 s. Generally, cold blood cardioplegia was delivered in an antegrade fashion via aortic root after aortic cross-clamping. For patients undergoing OPCAB, heparin was given to reach an activated clotting time of at least 300 s. Body temperature was maintained between 32 C and 34 C to avoid hypothermia-induced ventricular arrhythmia. An Octopus stabilizer (Medtronic Inc., Minneapolis, MN, USA) was routinely used for distal anastomoses.
Definitions and clinical follow-up
The primary early outcomes of interest were mortality and major postoperative complications (postoperative bleeding, low cardiac output syndrome, sternal wound infection, pneumonia, stroke, new-onset dialysis, atrial fibrillation and prolonged ventilation greater than 24 h) that occurred within 30 days of surgery or during hospitalization. Low cardiac output syndrome was defined as the requirement for postoperative intra-aortic balloon pump or extracorporeal membrane oxygenation. Sternal wound infection was defined by the involvement of the sternum (sternal osteomyelitis) with/without retrosternal infection.
The primary long-term outcome of interest was all-cause mortality. Other outcomes of interest were the composite of major adverse cardiac events (MACE), including myocardial infarction, repeat revascularization, cerebrovascular accident and hospitalization due to cardiovascular causes. Clinical follow-up data were obtained every 3-6 months via outpatient clinic visits. Patients with concomitant mitral or tricuspid valve pathologies were evaluated with echocardiography every 6-12 months during follow-up.
Statistical analysis
Categorical variables were expressed in frequencies or percentages and continuous variables as mean ± standard deviation or median with range. We compared categorical variables with the v 2 test with the Yates' continuity correction factor and continuous variables with the Student's t-test. The Kaplan-Meier curves were made to delineate each group's survival and MACE-free survival. Log-rank tests were performed to compare the inter-group differences in survival outcomes.
To adjust for differences in the patient's baseline characteristics between the 2 groups, we used propensity score (PS)-based inverse probability of treatment weighting (IPTW) technique [15] . The PS was the probability that the patient receives OPCAB in either of the 2 groups. The PSs were estimated with the multiple logistic regression analysis incorporating the 31 baseline variables presented in Table 1 .
We found out that the year of entry and the operator factor affected the operative approach regarding CPB use. The patients were divided into 2 groups based on their operative years-before and after 2008-because 2 surgeons preferring on-pump strategy left our hospital in 2008. The 7 operating surgeons involved in this study were grouped based on the CPB strategy and the year of entry into CABG, thereby operative year and operator factor were incorporated into the estimation of PS.
With the IPTW technique, the weights for patients receiving OPCAB were calculated using the formula 1/PS, whereas the weights for patients receiving on-pump CABG were calculated using the formula 1/(1 -PS); the IPTW adjustment was based on stabilized weights with robust standard errors. Standardized mean differences were calculated to assess the balance between the 2 groups after adjustment [15, 16] . The weighted logistic regression and the weighted Cox proportional hazard model were used to evaluate the impact of CPB use on early and long-term clinical outcomes, respectively. The proportional hazards assumption in the Cox model was assessed using the Schoenfeld residuals. The adjusted Kaplan-Meier curves were formulated to delineate each group's survival and MACE-free survival [17] . We assumed that the impact of CPB strategies on the risks of mortality would differ in the early and late postoperative periods; thus, we performed a landmark survival analysis to validate this assumption.
All reported P-values were 2-sided, and the P-values of <0.05 were considered statistically significant. R software, version 3.4.0 (R Foundation, Vienna, Austria; http://www.R-project.org/) was used for statistical analysis.
RESULTS
Baseline characteristics and coronary grafting profiles
The baseline demographic and clinical characteristics of all patients in the on-and off-pump groups are summarized in Table 1 . Overall, the patients in the on-pump group demonstrated high-risk profiles compared with the off-pump group: they presented congestive heart failure (P = 0.038) and severe angina (Canadian Cardiovascular Society Class 3 or 4; P = 0.003) more frequently compared with the off-pump group. On echocardiographic assessment, the patients in the on-pump group had a poorer left ventricular ejection fraction (P = 0.003) with a larger left ventricular systolic (P = 0.018) and diastolic (P = 0.014) dimension compared with the off-pump group. Significant (> _Grade 3) mitral regurgitation was more common in the on-pump group (P = 0.001). Of a total of 31 patients with > _moderate tricuspid regurgitation, 30 patients had moderate tricuspid regurgitation (Grade 2 or 3) in the both groups, whereas only 1 patient in the off-pump group had severe tricuspid regurgitation (Grade 4).
The patients in the off-pump group had fewer distal anastomoses compared with those in the on-pump group (2.8 ± 1.0 vs 3.1 ± 0.9; P = 0.003) but used more arterial conduits (P = 0.001). Values are represented as n (%) or mean ± standard deviation, unless otherwise indicated. Saphenous vein graft was more frequently used in the on-pump group (89.8% vs 73.4%; P = 0.001) ( Table 2) .
Unadjusted clinical outcomes
Early mortality occurred in 11 of 118 (9.3%) patients in the onpump group and 2 of 203 (1.0%) patients in the off-pump group (P = 0.001). Early major morbidities were more frequent in the on-pump group than the off-pump group: postoperative bleeding (P = 0.029), sternal wound infection (P = 0.006) and prolonged ventilation (P = 0.014). Postoperative intensive care unit (P < 0.001) and hospital stays (P = 0.001) were also significantly longer in the on-pump group (Table 3) . Follow-up was complete in 279 (86.9%) patients. During a median follow-up of 56.0 (interquartile range 22.7-90.3) months, 89 (75.4%) and 97 (47.8%) patients died in the on-and off-pump groups, respectively. There were no significant inter-group differences in the occurrence of MACE (P = 0.616) ( Table 3 ). The Kaplan-Meier analysis showed significant differences in survival (P = 0.003) and MACE-free survival rates (P = 0.020) in favour of the off-pump strategy (Fig. 1) .
Adjusted clinical outcomes
After weighting, the baseline characteristics were well balanced between the 2 groups with standardized mean differences <10% for most covariates (Supplementary Material, Table S1 ). Table 4 summarizes the results of the unadjusted and adjusted risk analyses for early and long-term clinical outcomes by CPB use. The results of the Schoenfeld residuals suggested no evidence to reject the assumption of proportionality for the off-pump strategy with respect to the long-term outcomes (Table 4) . After an adjustment, the off-pump strategy was found to be associated with a significant risk reduction for several early outcomes: early death (P = 0.002), bleeding (P = 0.006), sternal wound infection (P = 0.002), pneumonia (P = 0.035) and prolonged ventilation (P < 0.001). Regarding the long-term outcomes, the weighted Cox model showed that the off-pump strategy was associated with a significant risk reduction in overall mortality [hazard ratio (HR) 0.61, 95% confidence interval (CI) 0.46-0.81; P < 0.001] and the composite of mortality and MACE (HR 0.67, 95% CI 0.51-0.88; P = 0.004). However, the risk of MACE, including the composite of myocardial infarction and revascularization (P = 0.965) and late cerebrovascular accident (P = 0.656), did not differ significantly Early outcomes are given as OR; long-term outcomes are given as HR. b Cox proportional hazards assumption (by the Schoenfeld residuals): overall death (P = 0.162), late CVA (P = 0.152), MI + revascularization (P = 0.898), MACE (P = 0.917) and Death + MACE (P = 0.270). CI: confidence interval; CVA: cerebrovascular accident; HR: hazard ratio; IPTW: inverse probability of treatment weighting; LCOS: low cardiac output syndrome; MI: myocardial infarction; MACE: major adverse cardiac event; MCS: mechanical circulatory support; OR: odds ratio. between the 2 groups (Fig. 2) . The landmark survival analysis revealed that the mortality risk in the off-pump group was significantly lower within 1 year (HR 0.23, 95% CI 0.12-0.44; P < 0.001), whereas the mortality risk (HR 0.80, 95% CI 0.58-1.12; P = 0.198) between the 2 groups became comparable after 1 year (Fig. 3) . When the IPTW adjustment was further refined by multivariable analyses with operator, which was significantly imbalanced after weighting, the off-pump strategy still showed lower risks for several early outcomes (death, bleeding, sternal wound infection and prolonged ventilation) and overall death with or without MACE (Table 4) .
DISCUSSION
This study demonstrated that CPB use is closely associated with higher risks for early mortality and several postoperative complications. In addition, the off-pump strategy was found to increase survival benefits compared with the on-pump strategy, particularly in the early postoperative period. These results are drawn from a reasonably sized cohort data set large enough to support a statistical analysis to compare the clinical outcomes between the 2 strategies. A rigorous risk-adjustment methodology was used to adequately balance the baseline covariates across these 2 high-risk groups. In our previous study [8] that compared the mortality outcomes between the on-and off-pump CABG groups, we demonstrated that early mortality was comparable between the 2 groups (HR 1.11, 95% CI 0.74-1.65; P = 0.62), whereas the offpump group was at a significantly higher risk of overall death (HR 1.43, 95% CI 1.19-1.71; P < 0.001) compared with the onpump group. Although an enhanced survival with the on-pump technique was consistently demonstrated across most of the risk subgroups, the survival benefit tended to be attenuated in the subgroup of patients with estimated glomerular filtration rate of <20 ml/min/1.73 m 2 with significant interaction (P = 0.045). These results implied that a survival benefit by the on-pump strategy may vary across the subgroups based on kidney function, which urged us to further evaluate the impact of CPB strategy during CABG in patients with severe CKD.
The benefits of off-pump strategy, such as decreasing early mortality and complications in the high-risk patients, have been advocated in several large-scale observational studies [6, 7, 18] . Such early benefits of the off-pump strategy also seemed to be appealing to the high-risk patients dependent on haemodialysis. Dewey et al. [12] evaluated 158 patients on haemodialysis undergoing CABG. They reported that CPB use is a significant determinant of early death (OR 13.6, 95% CI 1.7-110; P = 0.01) and is more likely to result in prolonged ventilation (28.3% vs 6.8%; P = 0.001). Additionally, other studies observed that CPB use was associated with an increased risk of early death or new-onset atrial fibrillation in patients with severe CKD as well [10, 11, 19] .
The early outcomes of this study are consistent with those in the aforementioned previous studies. We identified a significant between-group difference in the risk of early death (P = 0.002), postoperative bleeding (P = 0.006), sternal wound infection (P = 0.002) and prolonged ventilation (P < 0.001) favouring the off-pump strategy after adjustment. Physiological derangement by acute inflammatory response and coagulopathy inherent to CPB use may unbalance a fragile situation in a patient with severe comorbidities, thereby resulting in respiratory/renal insufficiency and haemodynamic instability after cardiac surgery [20] . Also, patients receiving the beating-heart off-pump surgery have the benefit of avoiding ischaemia/reperfusion injury. We assumed that benefits of avoiding the detrimental effect of CPB use may be more prominently manifested in these high-risk patients who are incapable of withstanding such damages from CPB use. Also, patients with severe CKD, prone to accelerated atherosclerosis [2] , may be subject to a higher risk of embolic stroke associated with CPB use by aortic cannulation and cross-clamping.
In contrast to the early outcomes, the long-term survival outcomes were contradictory with the previous studies; Boulton et al. [11] reported poorer long-term survival in patients with severe CKD undergoing OPCAB, whereas the survival analysis using the United States Renal Data System (USRDS) database consistently revealed a decreased risk of all-cause mortality with the offpump strategy [10, 13] . Along with the results from USRDS data, our study also reiterated the long-term survival benefit in the offpump group. However, these favourable long-term outcomes with the off-pump strategy seemed to contradict those from several randomized controlled trials and large-scale observational studies that demonstrated superior survival benefits in the onpump group [8, 9, 21, 22] .
Such poorer survival outcomes associated with the off-pump strategy in the previous studies have been attributed to the relatively incomplete total revascularization and inferior long-term graft patency [23, 24] . In this study, significantly more target vessels were bypassed in the on-pump group compared with the off-pump group as well. Although we were not able to evaluate the long-term graft patency in this study, the off-pump technique did not significantly influence the risk of the composite of myocardial infarction and revascularization (P = 0.918).
The mechanisms by which these 2 indexes-complete revascularization and graft patency-have affected survival outcomes in this study need further clarification; a possible explanation might be that the purported survival benefits of the on-pump strategy are limited in patients with severe CKD by the shorter life expectancy inherent to this morbid condition [25] . Rather, the off-pump strategy, despite the fewer number of graft anastomoses, may be more advantageous to survival by avoiding deleterious inflammatory/embolic risks and coagulopathy associated with CPB use. It is particularly noteworthy that the landmark survival analysis showed that CPB use did not significantly influence the risk of overall mortality after 1 year (HR 0.80, 95% CI 0.58-1.12; P = 0.198), implying that the inter-group difference in the overall mortality was mostly attributable to the difference in the early postoperative period. The results of landmark analysis support our view that CPB use could significantly contribute to increasing the risk of mortality in this high-risk cohort, specifically in the short term.
Limitations
This study is subject to the limitations inherent to a single-centred study with a retrospective and observational design. As in any study retrospectively evaluating surgical outcomes after CABG, one may anticipate surgical bias in the choice of CPB use and revascularization strategies. Our study cohort included cases performed by 7 operating surgeons with different preferences of the CPB strategies and conduit choices. Although all surgeons were experienced and had a similar level of surgical expertise, it is possible that unmeasured residual confounders may have affected the study results despite using rigorous statistical adjustment. Also, intraoperative revascularization strategies in terms of conduit choices have evolved throughout the 20-year study period in our institution. The discrepancies between the 2 groups regarding the revascularization strategy were not reflected during statistical adjustment, but we speculated that the early clinical outcomes were barely affected by the conduit choices between the 2 groups based on the similar level of surgical expertise across the surgeons in this study. Finally, our institution runs one of the most enthusiastic off-pump CABG programmes in the world [8] ; as such, our study results may not be generalizable to other centres with varying degrees of expertise in performing offpump procedures. Thus, our results should be interpreted cautiously, and a prospective randomized trial may be necessary to further validate the conclusion of the study.
CONCLUSIONS
The use of CPB in performing CABG for patients with severe CKD was associated with a significantly higher risk of mortality and morbidities; the difference in overall mortality between the 2 groups may be attributable to the increased risks inherent to CPB use in the early postoperative period. These results suggest that the off-pump strategy might be preferable in performing CABG whenever technically feasible, despite potentially incomplete revascularization in patients with severe CKD.
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